Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine - Wikidata - awgldk - TriplyDB

Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine

Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine

http://www.wikidata.org/entity/Q34661613

about

Brain oscillations in bipolar disorder and lithium-induced changes Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.Towards medication-enhancement of cognitive interventions in schizophrenia The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia The role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophrenia Acute NMDA receptor antagonism disrupts synchronization of action potential firing in rat prefrontal cortex Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia The qEEG Signature of Selective NMDA NR2B Negative Allosteric Modulators; A Potential Translational Biomarker for Drug Development Observation of Distressed Conspecific as a Model of Emotional Trauma Generates Silent Synapses in the Prefrontal-Amygdala Pathway and Enhances Fear Learning, but Ketamine Abolishes those Effects Spontaneous Gamma Activity in Schizophrenia.Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine.Effects of NMDA and GABA-A Receptor Antagonism on Auditory Steady-State Synchronization in Awake Behaving Rats Brain state-dependent abnormal LFP activity in the auditory cortex of a schizophrenia mouse model.How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.Predictive suppression of cortical excitability and its deficit in schizophrenia.Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations.Augmented gamma band auditory steady-state responses: support for NMDA hypofunction in schizophrenia Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia.Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism.Ketamine Alters Outcome-Related Local Field Potentials in Monkey Prefrontal Cortex.In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept Scaling brain size, keeping timing: evolutionary preservation of brain rhythms.Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia Reviewing the ketamine model for schizophrenia.New targets for rapid antidepressant action.Exploring the impact of ketamine on the experience of illusory body ownership Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia Electroencephalographic coherence and cortical acetylcholine during ketamine-induced unconsciousness.Delta frequency optogenetic stimulation of the thalamic nucleus reuniens is sufficient to produce working memory deficits: relevance to schizophrenia.Baseline gamma power during auditory steady-state stimulation in schizophrenia Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors Sustained Modafinil Treatment Effects on Control-Related Gamma Oscillatory Power in Schizophrenia.State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 - Relation to antipsychotic-like drug effects Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.Exposure to Early Life Pain: Long Term Consequences and Contributing Mechanisms.

P2860

Q26750446-CB09CE6A-0F0D-4191-9889-10F0AF2E8821 Q26830533-05D4B214-7C89-4FA0-9DA9-39BB20DC1F10 Q26860777-C8898E15-D27A-46A6-BC03-3C2BB09C92B6 Q27023087-4C7F073B-7D81-44A9-A242-15038D5B853C Q27026637-BE474A1E-A668-4DA7-9314-8CF5BC7A605B Q27332387-8C5A28C9-7144-4D0E-84BF-9A569ABFC875 Q28275290-5912967D-B240-4E82-B2DF-A08112A6D648 Q28551131-499EAF88-CD9D-47EE-A140-6D3C5C2DE60A Q30300197-9AD35683-DAAB-4DF0-A03F-3E617280F688 Q30377860-8557AC36-A2DE-445A-B304-1DAED190ED3D Q30383064-3F6A69DD-D1D7-4683-8166-E55B20B3DE8F Q30403781-0ADCCEED-DC90-44AC-AAEE-9A8616598991 Q30435025-FA48DA82-4667-434A-A1A7-62F17FDACB1F Q30439924-DFD489A2-C8ED-4098-ACFF-17111FC246E4 Q30444541-7438A0C9-29CB-4DFA-B9FC-0B52D03D0933 Q30453949-1B80D9EB-4D1F-4B67-A432-717B703EC197 Q30454156-127767EB-F096-4CC4-A0AB-E30275BF88E2 Q30455798-465DEC05-6170-4AB0-8135-10769127A9DC Q30466734-267B8912-2D2B-4DB2-8B51-E4EA3B7A86E2 Q30727742-711F764F-F542-469A-8E03-226DD2FAA570 Q30758231-ED28B8D1-3B2A-4D84-8360-69968471D73E Q30976220-0A98B578-DD9E-413D-BFC3-930B7B44A0A7 Q33564885-2D949030-F256-4441-A429-3B39911CAE86 Q33647885-616FC2D9-CE34-4192-9B33-553D9190E24A Q34046060-D5E6C937-C027-4A3C-8837-EF8F55E51E34 Q34507177-4F27AE28-929B-4729-9EEF-74A2985F0592 Q34512497-B7970778-ADC7-4811-B968-B331EEEA82F4 Q34583614-9E52A992-9A51-4FF3-8437-F2788453F871 Q35622231-520DB718-7588-417F-91C2-B939BCF0286A Q35648766-B98D58BF-711D-4B89-9839-EC98A002ED2E Q35702202-4D48FF37-049D-4B61-A758-B5B781EE62C1 Q35968145-BF3A83F9-6E88-4CAC-BDDB-5A4B991308BE Q36042941-85D6D1BE-ED79-445E-848E-71011804FAFD Q36128314-F690BFFF-AC6D-4549-A572-F7BE27268C03 Q36245009-C6C6086B-E712-4589-B74A-3F8CFCF44A5E Q36446517-42D83881-CE88-44AC-86CD-43A12589FE7F Q36690640-CCABC694-8FBC-4035-9E38-6325A73958A8 Q36732752-4718E0AE-F0B9-4A76-BF05-FB5917F5153D Q36798980-BDB22AC5-74F4-4E23-90CF-B7B1608E1211 Q37163818-604E0920-360C-4A3B-AE11-9CEF00031B67

P2860

Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine

http://www.wikidata.org/entity/Q34661613

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Gamma and delta neural oscilla ...... s under subanesthetic ketamine

@ast

Gamma and delta neural oscilla ...... s under subanesthetic ketamine

@en

Gamma and delta neural oscilla ...... s under subanesthetic ketamine

@nl

type

label

Gamma and delta neural oscilla ...... s under subanesthetic ketamine

@ast

Gamma and delta neural oscilla ...... s under subanesthetic ketamine

@en

Gamma and delta neural oscilla ...... s under subanesthetic ketamine

@nl

prefLabel

Gamma and delta neural oscilla ...... s under subanesthetic ketamine

@ast

Gamma and delta neural oscilla ...... s under subanesthetic ketamine

@en

Gamma and delta neural oscilla ...... s under subanesthetic ketamine

@nl

P1433

Q34661613-B8DCD434-2557-423E-AFD8-75B9CFD1D4C3

P1476

Q34661613-4C96AD7E-0730-4EE9-A975-FE55808E82CA

P2093

Q34661613-77A70A82-0FDC-46C3-B4A9-4C8C1E7449EF

Q34661613-933BAE93-B041-4AE3-930B-022ADE8938CE

Q34661613-97D70374-EC5E-4B08-968A-CC49188BC495

Q34661613-CD64FC14-00A4-4E1D-BB47-E3F620A2F6B2

Q34661613-DF86779F-351B-432C-9C6C-483029CC7C99

Q34661613-EEBF28E3-C977-498B-9FE6-BA840FCDD575

P2860

Q34661613-05AD9BD8-71B1-4BBD-BE22-7349980A08B1

Q34661613-0968CD27-649B-4EB1-9D56-3B3F9A515C86

Q34661613-097FE339-7314-4B7B-A1D7-6D9BFBE2436E

Q34661613-09FF6A63-4D09-4E14-9183-6B3C35492A35

Q34661613-0A80E9AE-87AE-46BB-9FC4-B7D7D2592A00

Q34661613-0AE14B1D-22AB-42B0-AEE3-42DE25449828

Q34661613-14376E83-D272-4F4F-962E-33225C8892C8

Q34661613-21134475-8F5B-4524-85B3-2E9AFB711296

Q34661613-2535C84D-0EFD-451F-9F36-201974387847

Q34661613-280E8BB5-967B-4930-87DD-57FB8A3F461F

P2888

Q34661613-5B140534-AEAE-406D-BEDD-852BA33DF29D

P304

Q34661613-36DEB152-292E-4E8B-85B6-76979FD708E8

P31

Q34661613-8AC8F160-4A45-48A3-BAA7-60B85FB2C707

P356

Q34661613-D03BF81E-E99D-4EDC-9621-995534917C98

P407

Q34661613-A06113D2-86B1-4058-BE22-2853033B0ED6

P433

Q34661613-72B059A3-8360-4F5B-BB3E-A332C416F9CB

P478

Q34661613-914600E3-CCFE-4309-8154-499C1FEB58B5

P50

Q34661613-B4A11979-7DB2-4D1B-8EB5-44CB2B3C825C

P577

Q34661613-1CE3F387-5F64-4DC3-9761-20A9B37D0D40

P5875

Q34661613-94C5ACD9-5D27-4F46-8D5A-C2E2A03FF8E5

P6179

Q34661613-AEA12ADD-29ED-4BEB-8545-605118D143C4

P698

Q34661613-8F976913-3369-4FE1-83DE-0A9F90B59D8A

P932

Q34661613-29565738-FA4D-49B1-93F1-242470C6700A

P356

P1433

Neuropsychopharmacology

P1476

Gamma and delta neural oscilla ...... s under subanesthetic ketamine

@en

P2093

Adrienne C Lahti

http://www.w3.org/2001/XMLSchema#string

Ann Summerfelt

http://www.w3.org/2001/XMLSchema#string

Gunvant K Thaker

http://www.w3.org/2001/XMLSchema#string

L Elliot Hong

http://www.w3.org/2001/XMLSchema#string

Martin A Weiler

http://www.w3.org/2001/XMLSchema#string

Robert W Buchanan

http://www.w3.org/2001/XMLSchema#string

P2860

GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia

Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials.

Gamma frequency-range abnormalities to auditory stimulation in schizophrenia.

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders.

Effects of ketamine in normal and schizophrenic volunteers.

Low dose ketamine increases prepulse inhibition in healthy men.

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.

Neural synchrony indexes disordered perception and cognition in schizophrenia.

P2888

P304

632-640

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2009.168

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Patricio O'Donnell

P577

2009-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38067907

http://www.w3.org/2001/XMLSchema#string

P6179

1016916348

http://www.w3.org/2001/XMLSchema#string

P698

19890262

http://www.w3.org/2001/XMLSchema#string

P932

3055615

http://www.w3.org/2001/XMLSchema#string